The life science group Sartorius launches the new Octet ® R8e biolayer interferometry (BLI) system, providing researchers with its most advanced detection capabilities to date for real-time, ...
Scientists from the Miller School of Medicine at the University of Miami have reported their recent work to develop small-molecule inhibitors of the CD40-CD40L (CD154) costimulatory protein-protein ...
After three years of internal development, Expedition is building a generative AI platform for covalent drug discovery, supported by a $50M initial commitment from Flagship Pioneering Multi-target ...
Ian Quigley was employee #13 at AI drug company Recursion until 2021, when he quit and turned the basement of his Utah home into a lab to develop AI models for predicting which proteins small molecule ...
In an important new paper forthcoming in the June issue of The Quarterly Review of Biology, Robert Shapiro (New York University) argues against the widely held theory that the origin of life began ...
Five years after launching one of the most promising generative biology drug discovery companies, Generate Biomedicines, venture capital powerhouse Flagship Pioneering has brought a generative ...
AZoLifeSciences on MSN
Identifying molecules that activate and inhibit key protein function
Researchers at Northwestern University have discovered a concealed molecular "control switch" within a protein that plays a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback